Literature DB >> 16361147

Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT).

Paul M Silverman1, Janio Szklaruk.   

Abstract

Primary hepatocellular carcinoma (HCC) is a significant tumor worldwide and represents the most common primary hepatic neoplasm. Staging criteria are important for appreciation of timely work up of these neoplasms in contradiction with surgical colleagues. This article demonstrates the appearance of HCC on multiphasic, multidetector CT (MDCT) and relates these findings to current staging criteria. The variable appearance on different planes of contrast is critical to appreciate in staging this neoplasm. The hypervascular nature of the primary tumor makes MDCT and three-phase imaging a critical feature in the detection and characterization of this tumor. This is especially critical in the patients who are candidates for surgical resection. Additionally, MDCT has allowed arterial phase imaging to define the vascular supply of the tumor. An accurate representation of the size and number of lesions is critical in not only the initial staging but also the follow-up of hepatocellular carcinoma. The post-treatment features including the appearance post-surgically and after radiofrequency ablation can be well appreciated on MDCT. International Cancer Imaging Society.

Entities:  

Mesh:

Year:  2005        PMID: 16361147      PMCID: PMC1665245          DOI: 10.1102/1470-7330.2005.0105

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN: 1470-7330            Impact factor:   3.909


  29 in total

1.  Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography.

Authors:  M Kanematsu; J H Oliver; B Carr; R L Baron
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

2.  Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

Authors:  J W Marsh; I Dvorchik; C A Bonham; S Iwatsuki
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

3.  MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography.

Authors:  J S Yu; K W Kim; J T Lee; H S Yoo
Journal:  AJR Am J Roentgenol       Date:  1998-06       Impact factor: 3.959

4.  Well-differentiated hepatocellular carcinoma: findings of US, CT, and MR imaging.

Authors:  S Monzawa; K Omata; N Shimazu; A Yagawa; K Hosoda; T Araki
Journal:  Abdom Imaging       Date:  1999 Jul-Aug

5.  Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.

Authors:  T W Leung; Y Z Patt; W Y Lau; S K Ho; S C Yu; A T Chan; T S Mok; W Yeo; C T Liew; N W Leung; A M Tang; P J Johnson
Journal:  Clin Cancer Res       Date:  1999-07       Impact factor: 12.531

6.  Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.

Authors:  E M Loyer; H Chin; R A DuBrow; C L David; F Eftekhari; C Charnsangavej
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

7.  Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.

Authors:  J C Luo; S J Hwang; J C Wu; C P Li; L T Hsiao; C R Lai; J H Chiang; W Y Lui; F Y Chang; S D Lee
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

Review 8.  Diagnostic imaging and interventional therapy of hepatocellular carcinoma.

Authors:  L D Palma
Journal:  Br J Radiol       Date:  1998-08       Impact factor: 3.039

9.  Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers.

Authors:  C B Winston; L H Schwartz; Y Fong; L H Blumgart; D M Panicek
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

10.  Hepatocellular carcinoma outcomes based on indicated treatment strategy.

Authors:  A T Rose; D M Rose; C W Pinson; J K Wright; T Blair; C Blanke; D Delbeke; J P Debelak; W C Chapman
Journal:  Am Surg       Date:  1998-12       Impact factor: 0.688

View more
  5 in total

1.  Novel Mahalanobis-based feature selection improves one-class classification of early hepatocellular carcinoma.

Authors:  Ricardo de Lima Thomaz; Pedro Cunha Carneiro; João Eliton Bonin; Túlio Augusto Alves Macedo; Ana Claudia Patrocinio; Alcimar Barbosa Soares
Journal:  Med Biol Eng Comput       Date:  2017-10-16       Impact factor: 2.602

2.  Mastalgia as an atypical presentation of hepatocellular carcinoma: a case report.

Authors:  AbdulAziz Mohammad Al-Sharydah; Abdulrhman Hamad Al-Abdulwahhab; Ibrahim Abobaker Alghnimi; Mohammed A El Shawarby; Faisal Ahmad Katbi
Journal:  World J Surg Oncol       Date:  2017-03-09       Impact factor: 2.754

Review 3.  Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.

Authors:  Liang Wang
Journal:  Hepat Med       Date:  2010-08-17

Review 4.  Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments.

Authors:  Woubet Tefera Kassahun
Journal:  World J Surg Oncol       Date:  2016-05-23       Impact factor: 2.754

5.  Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.

Authors:  Qi-wen Chen; Hai-jin Li; Ya-nan Chen; Zhou-yu Ning; Song Gao; Ye-hua Shen; Zhi-qiang Meng; Sonya Vargulick; Bi-yun Wang; Hao Chen
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.